Empagliflozin on Cardiac-renal Injury in Patients With STEAMI Patients After Primary PCI
Clinical trial NCT03591991 · UNKNOWN
Trial details
- NCT number
- NCT03591991
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2019-01-31
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.